Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intra-Cellular Therapies Inc (NASDAQ:ITCI)

During the Trading Day
29.33 -0.09 / -0.31%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
29.28 -0.0545 / -0.19%
 
Volume: 742.00

Today’s Trading

Previous close29.42
Today’s open29.20
Day’s range28.33 - 30.12
Volume202,640
Average volume (3 months)302,570
Market cap$1.0B
Dividend yield--
Data as of 3:59pm ET, 07/30/2015

Growth & Valuation

Earnings growth (last year)+31.41%
Earnings growth (this year)-181.31%
Earnings growth (next 5 years)--
Revenue growth (last year)-78.91%
P/E ratioNM
Price/Sales875.93
Price/Book7.20

Competitors

 Today’s
change
Today’s
% change
DVAXDynavax Technologies...-0.43-1.45%
ARNAArena Pharmaceutical...-0.12-2.93%
ACHNAchillion Pharmaceut...-0.02-0.24%
SUPNSupernus Pharmaceuti...-0.05-0.24%
Data as of 4:14pm ET, 07/30/2015

Financials

Next reporting dateAugust 11, 2015
EPS forecast (this quarter)-$0.72
Annual revenue (last year)$577.3K
Annual profit (last year)-$30.7M
Net profit margin-5,316.37%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Sharon Mates
CFO, Treasurer &
Vice President-Finance
Lawrence J. Hineline
Corporate headquarters
New York, New York

Forecasts